Vaccination with a DNA and MVA ‘Prime-Boost’ Regimen Induces Strong CD8+ T-Cell Responses Against the Immunodominant Minor Histocompatibility Antigen, HA-1: Results of a First-in-Man Phase I Clinical Trial

Autor: Inman, Charlotte F ^*, Eldershaw, Suzy A ^*, Pearce, Hayden ^*, Abbotts, Ben E ^*, Sirovica, Mirjana ^*, Ferguson, Paul ^*, Walsh, Donna L ^*, Nunnick, Jane ^*, Siddique, Shamyla ^*, Moss, Paul, Malladi, Ram K ^*

Publikováno v: In Blood 8 December 2017 130 Supplement 1:1908-1908

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Biaxial flex‐fatigue and viral penetration of natural rubber latex gloves before and after artificial aging

Autor: Schwerin, Matthew R., Walsh, Donna L., Coleman Richardson, D., Kisielewski, Richard W., Kotz, Richard M., Routson, Licia B., David Lytle, C.

Publikováno v: Journal of Biomedical Materials Research; 2002, Vol. 63 Issue: 6 p739-745, 7p

Vaccination with a DNA and MVA ‘Prime-Boost’ Regimen Induces Strong CD8+T-Cell Responses Against the Immunodominant Minor Histocompatibility Antigen, HA-1: Results of a First-in-Man Phase I Clinical Trial

Autor: Inman, Charlotte F, Eldershaw, Suzy A, Pearce, Hayden, Abbotts, Ben E, Sirovica, Mirjana, Ferguson, Paul, Walsh, Donna L, Nunnick, Jane, Siddique, Shamyla, Moss, Paul, Malladi, Ram K

Publikováno v: Blood; December 2017, Vol. 130 Issue: 1, Number 1 Supplement 1 p1908-1908, 1p

Feasibility and Acceptability of a Web Site to Promote Survivorship Care in Survivors of Hodgkin Disease.

Autor: Underhill ML; Meghan L. Underhill, Fangxin Hong, Kim Sprunck-Harrild, Sarah K. Walsh, Donna L. Berry, and Ann Partridge, Dana-Farber Cancer Institute; Richard Boyajian, Brigham and Women's Hospital Boston, MA; and Tarsha Jones, Florida Atlantic University, Boca Raton, FL., Hong F; Meghan L. Underhill, Fangxin Hong, Kim Sprunck-Harrild, Sarah K. Walsh, Donna L. Berry, and Ann Partridge, Dana-Farber Cancer Institute; Richard Boyajian, Brigham and Women's Hospital Boston, MA; and Tarsha Jones, Florida Atlantic University, Boca Raton, FL., Jones T; Meghan L. Underhill, Fangxin Hong, Kim Sprunck-Harrild, Sarah K. Walsh, Donna L. Berry, and Ann Partridge, Dana-Farber Cancer Institute; Richard Boyajian, Brigham and Women's Hospital Boston, MA; and Tarsha Jones, Florida Atlantic University, Boca Raton, FL., Sprunck-Harrild K; Meghan L. Underhill, Fangxin Hong, Kim Sprunck-Harrild, Sarah K. Walsh, Donna L. Berry, and Ann Partridge, Dana-Farber Cancer Institute; Richard Boyajian, Brigham and Women's Hospital Boston, MA; and Tarsha Jones, Florida Atlantic University, Boca Raton, FL., Walsh SK; Meghan L. Underhill, Fangxin Hong, Kim Sprunck-Harrild, Sarah K. Walsh, Donna L. Berry, and Ann Partridge, Dana-Farber Cancer Institute; Richard Boyajian, Brigham and Women's Hospital Boston, MA; and Tarsha Jones, Florida Atlantic University, Boca Raton, FL., Boyajian R; Meghan L. Underhill, Fangxin Hong, Kim Sprunck-Harrild, Sarah K. Walsh, Donna L. Berry, and Ann Partridge, Dana-Farber Cancer Institute; Richard Boyajian, Brigham and Women's Hospital Boston, MA; and Tarsha Jones, Florida Atlantic University, Boca Raton, FL., Berry DL; Meghan L. Underhill, Fangxin Hong, Kim Sprunck-Harrild, Sarah K. Walsh, Donna L. Berry, and Ann Partridge, Dana-Farber Cancer Institute; Richard Boyajian, Brigham and Women's Hospital Boston, MA; and Tarsha Jones, Florida Atlantic University, Boca Raton, FL., Partridge A; Meghan L. Underhill, Fangxin Hong, Kim Sprunck-Harrild, Sarah K. Walsh, Donna L. Berry, and Ann Partridge, Dana-Farber Cancer Institute; Richard Boyajian, Brigham and Women's Hospital Boston, MA; and Tarsha Jones, Florida Atlantic University, Boca Raton, FL.

Publikováno v: JCO clinical cancer informatics [JCO Clin Cancer Inform] 2017 Nov; Vol. 1, pp. 1-10.